Notice: Undefined offset: 1 in /var/www/jopcr.com/article-detail-page.php on line 103
The Truth About Diabetic Eye Screening: A Deep Dive into Diagnostic Accuracy
 
  • P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

The Truth About Diabetic Eye Screening: A Deep Dive into Diagnostic Accuracy
  • VIEWS 7
  • PDF 5

Journal of Pharmaceutical Research

DOI: 10.18579/jopcr/v24.i3.82

Year: 2025, Volume: 24, Issue: 3, Pages: 150–160

Review Article

The Truth About Diabetic Eye Screening: A Deep Dive into Diagnostic Accuracy

Ragni Kumari1,∗

1Assistant Professor, Department of Optometry, UPUMS, Saifai, Etawaha, U.P., India

*Corresponding Author
Email: ragnimishraa@gmail.com

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Diabetic retinopathy (DR) is a leading cause of preventable blindness worldwide, emphasizing the importance of early detection through effective screening methods. The diagnostic accuracy of various DR screening techniques, including direct ophthalmoscopy, retinal photography, and telemedicine, remains a critical factor in improving clinical outcomes. This review aims to evaluate and compare the sensitivity, specificity, and overall diagnostic performance of different DR screening methods. Objective of the study is to assess the diagnostic accuracy of DR screening methods, including retinal photography, telemedicine, direct ophthalmoscopy, and other emerging technologies. A comprehensive literature search was conducted across databases including PubMed, Scopus, and Google Scholar up to May 2025. Studies involving adult diabetic populations and evaluating screening methods such as direct ophthalmoscopy, retinal photography, slit-lamp examination, and tele-retinal screening were included. Data on sensitivity, specificity, and other diagnostic metrics were extracted by an independent reviewer. The quality of included studies was assessed using the QUADAS-2 tool. Due to heterogeneity among studies, a narrative synthesis was performed without meta-analysis. Various screening methods showed differing diagnostic accuracies influenced by technology, examiner expertise, and population characteristics. Retinal photography, especially with mydriasis, demonstrated higher sensitivity and specificity compared to direct ophthalmoscopy. Tele-retinal screening showed promise in improving access in remote cohorts. However, variability in study designs and outcome reporting limited direct comparison. This review highlights that retinal photography, particularly when combined with telemedicine, offers the most reliable screening method for DR in terms of diagnostic accuracy. However, emerging technologies such as AI-based systems may improve detection rates in the future. Further high-quality, large-scale studies are needed to validate these findings and optimize screening protocols, especially in resource-limited settings.

Keywords: Diabetic retinopathy, Screening, Diagnostic accuracy, Retinal photography, Telemedicine

References

  1. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105(6):998–1003. Available from: https://doi.org/10.1016/s0161-6420(98)96025-0
  2. Wild SH, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030. Diabetes Care. 2004;27(5):1047–1053. Available from: https://doi.org/10.2337/diacare.27.5.1047
  4. Ferris FL. How Effective Are Treatments for Diabetic Retinopathy? JAMA: The Journal of the American Medical Association. 1993;269(10):1290–1291. Available from: https://doi.org/10.1001/jama.1993.03500100088034
  6. James M, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ. 2000;320(7250):1627–1631. Available from: https://doi.org/10.1136/bmj.320.7250.1627
  7. Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bulletin of the World Health Organization. 2004;82(11):844–851. Available from: https://pubmed.ncbi.nlm.nih.gov/15640920/
  8. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global Prevalence and Major Risk Factors of Diabetic Retinopathy. Diabetes Care. 2012;35(3):556–564. Available from: https://dx.doi.org/10.2337/dc11-1909
  9. Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of Diabetic Retinopathy in Various Ethnic Groups: A Worldwide Perspective. Survey of Ophthalmology. 2012;57(4):347–370. Available from: https://dx.doi.org/10.1016/j.survophthal.2012.01.004
  11. Roy MS, Klein R, O’colmain BJ, Klein BE, Moss SE, Kempen JH. The Prevalence of Diabetic Retinopathy Among Adult Type1 Diabetic Persons in the United States. Archives of Ophthalmology. 2004;122(4):546–551. Available from: https://doi.org/10.1001/archopht.122.4.546
  12. Ramachandran A, Snehalatha C, Sasikala R, Satyavani K, Vijay V. Vascular complications in young Asian Indian patients with Type 1 diabetes mellitus. Diabetes Research and Clinical Practice. 2000;48(1):51–56. Available from: https://dx.doi.org/10.1016/s0168-8227(99)00134-5
  13. Ko GTC, Chan JCN, Lau M, Cockram CS. Diabetic Microangiopathic Complications in Young Chinese Diabetic Patients. Journal of Diabetes and its Complications. 1999;13(5-6):300–306. Available from: https://dx.doi.org/10.1016/s1056-8727(99)00063-x
  14. Wong TY, Klein R, Islam FMA, Cotch MF, Folsom AR, Klein BEK, et al. Diabetic Retinopathy in a Multi-ethnic Cohort in the United States. American Journal of Ophthalmology. 2006;141(3):446–455. Available from: https://dx.doi.org/10.1016/j.ajo.2005.08.063
  15. Varma R, Paz SH, Azen SP, et al. The Los Angeles Latino Eye Study: design, methods, and baseline data. Ophthalmology. 2004;111(6):1121–1131. Available from: https://doi.org/10.1016/j.ophtha.2004.02.001
  17. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, et al. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44(2):156–163. Available from: https://dx.doi.org/10.1007/s001250051594
  18. Giuffre G, Lodato G, Dardanoni G. Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects: The Casteldaccia Eye Study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2004;242(7):535–540. Available from: https://doi.org/10.1007/s00417-004-0880-4
  19. Hamman RF, Mayer EJ, Moo-Young GA, Hildebrandt W, Marshall JA, Baxter J. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study. Diabetes. 1989;38(10):1231–1237. Available from: https://doi.org/10.2337/diab.38.10.1231
  20. Varma R, Ying-Lai M, Klein R, Azen SP. Prevalence and risk indicators of visual impairment and blindness in Latinos*1the Los Angeles Latino Eye Study. Ophthalmology. 2004;111(6):1132–1140. Available from: https://doi.org/10.1016/j.ophtha.2004.02.002
  21. Emanuele N, Sacks J, Klein R, Reda D, Anderson R, Duckworth W, et al. Ethnicity, Race, and Baseline Retinopathy Correlates in the Veterans Affairs Diabetes Trial. Diabetes Care. 2005;28(8):1954–1958. Available from: https://dx.doi.org/10.2337/diacare.28.8.1954
  22. Tapp RJ, Shaw JE, Harper CA, Courten MPd, Balkau B, McCarty DJ, et al. The Prevalence of and Factors Associated With Diabetic Retinopathy in the Australian Population. Diabetes Care. 2003;26(6):1731–1737. Available from: https://dx.doi.org/10.2337/diacare.26.6.1731
  23. Mitchell P, Smith W, Wang JJ, Attebo K. Prevalence of diabetic retinopathy in an older community. Ophthalmology. 1998;105(3):406–411. Available from: https://dx.doi.org/10.1016/s0161-6420(98)93019-6
  24. Mckay R, Mccarty CA, Taylor HR. Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project. British Journal of Ophthalmology. 2000;84(8):865–870. Available from: https://doi.org/10.1136/bjo.84.8.865
  25. PM, PSM, PB. Prevalence of vision-threatening diabetic retinopathy in Newcastle, Australia. The Tohoku Journal of Experimental Medicine. 1983;141(Suppl):379–383. Available from: https://dx.doi.org/10.1620/tjem.141.suppl_379
  26. Mitchell P. Development and progression of diabetic eye disease in Newcastle ( 1977-1984): rates and risk factors. Australian and New Zealand Journal of Ophthalmology. 1985;13(1):39–44. Available from: https://doi.org/10.1111/j.1442-9071.1985.tb00397.x
  27. He S, Guo Y, Li Z. Epidemiologic study of diabetic retinopathy in Capital Steel Company. Zhonghua Yan Ke Za Zhi. 1997;33(5):381–383. Available from: https://pubmed.ncbi.nlm.nih.gov/10451988/
  29. Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology. 2009;116(3):461–467. Available from: https://doi.org/10.1016/j.ophtha.2008.10.003
  30. Xie XW, Xu L, Wang YX, Jonas JB. Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graefe's Archive for Clinical and Experimental Ophthalmology. 2008;246(11):1519–1526. Available from: https://dx.doi.org/10.1007/s00417-008-0884-6
  32. Zoungas S, Chalmers J, Ninomiya T, Cooper ME, Li Q, Colagiuri S, et al. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia. 2012;55(3):636–643. Available from: https://dx.doi.org/10.1007/s00125-011-2404-1
  34. Lyons TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT, et al. Diabetic Retinopathy and Serum Lipoprotein Subclasses in the DCCT/EDIC Cohort. Investigative Opthalmology & Visual Science. 2004;45(3):910–918. Available from: https://dx.doi.org/10.1167/iovs.02-0648
  35. Keech AC, Mitchell P, Summanen PA, O'Day J, Davis TME, Moffitt MS, et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. The Lancet. 2007;370(9600):1687–1697. Available from: https://dx.doi.org/10.1016/s0140-6736(07)61607-9
  36. Lim LS, Tai ES, Mitchell P, Wang JJ, Tay WT, Lamoureux E, et al. C-reactive Protein, Body Mass Index, and Diabetic Retinopathy. Investigative Opthalmology & Visual Science. 2010;51(9):4458–4463. Available from: https://dx.doi.org/10.1167/iovs.09-4939
  37. Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M, et al. Markers of Insulin Resistance Are Strong Risk Factors for Retinopathy Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care. 2001;24(2):284–289. Available from: https://dx.doi.org/10.2337/diacare.24.2.284
  38. Hecke MVv, Dekker JM, Stehouwer CDA, Polak BCP, Fuller JH, Sjolie AK, et al. Diabetic Retinopathy Is Associated With Mortality and Cardiovascular Disease Incidence. Diabetes Care. 2005;28(6):1383–1389. Available from: https://dx.doi.org/10.2337/diacare.28.6.1383
  39. Henricsson M, Heijl A, Janzon L. Diabetic retinopathy before and after cataract surgery. British Journal of Ophthalmology. 1996;80(9):789–793. Available from: https://dx.doi.org/10.1136/bjo.80.9.789
  40. Suto C, Kitano S, Hori S. Optimal Timing of Cataract Surgery and Panretinal Photocoagulation for Diabetic Retinopathy. Diabetes Care. 2011;34(7):e123. Available from: https://doi.org/10.2337/dc11-0672
  41. Lim LS, Wong TY. Lipids and diabetic retinopathy. Expert Opinion on Biological Therapy. 2012;12(1):93–105. Available from: https://dx.doi.org/10.1517/14712598.2012.641531
  42. Meleth AD, Agro´n E, Chan CC, Reed GF, Arora K, Byrnes G, et al. Serum Inflammatory Markers in Diabetic Retinopathy. Investigative Opthalmology & Visual Science. 2005;46:4295–4301. Available from: https://dx.doi.org/10.1167/iovs.04-1057
  43. Leslie RD, Pyke DA. Diabetic retinopathy in identical twins. Diabetes. 1982;31(1):19–21. Available from: https://doi.org/10.2337/diab.31.1.19
  44. Looker HC, Nelson RG, Chew E, Klein R, Klein BEK, Knowler WC, et al. Genome-Wide Linkage Analyses to Identify Loci for Diabetic Retinopathy. Diabetes. 2007;56(4):1160–1166. Available from: https://dx.doi.org/10.2337/db06-1299

Copyright

© 2025 Published by Krupanidhi College of Pharmacy. This is an open-access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/) 

  • 21 October 2025

Year: 2025, Volume: 24, Issue: 3


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.